在患有不稳定心痛的患者中,高尿血和冠状动脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉
Dong-Chao Liu1, Liang Yin, Zheng Xue
1Department of Cardiology, Shijiazhuang People's Hospital, Shijiazhuang, China.
Medicine
|August 19, 2025
概括
高尿酸水平 (超尿血) 在皮肤冠状动脉干预 (PCI) 后显著增加了支架内静止症 (ISR) 的风险. 在PCI患者中查高尿血是监测和潜在的尿酸降低治疗的关键.
科学领域:
- 心脏病学 心脏病学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 静脉静脉复缩 (ISR) 是通过皮肤冠状动脉干预 (PCI) 后的一个显著并发症.
- 超尿血症是一种尿酸水平升高的症状,越来越多地认识到它在心血管疾病发病过程中的潜在作用.
研究的目的:
- 研究在接受PCI的不稳定性胸痛患者中,高尿血和ISR的发展之间的相关性.
- 确定高尿血症作为PCI后ISR的独立预测因子.
主要方法:
- 对128名接受PCI的不稳定性胸痛患者的临床数据的分析.
- 将患者分为高尿路血 (34例) 和非高尿路血 (94例) 组.
- 应用多变量考克斯回归模型来评估高尿血和ISR发展之间的关联.
主要成果:
- 与非高尿血症组 (13.8%) 相比,高尿血症组 (26.5%) 的ISR发生率显著更高 (P = .008).
- 在PCI (HR = 6.299,P = .002) 后,高尿路血症被确定为ISR的独立预测因子.
- 这种关联即使在调整了量化流量比率>0.89 (HR = 5.226,P = .010) 的患者的混因素后,也仍然显著.
结论:
- 患有高尿路血症的患者在PCI后面临着显著增加的ISR发展风险.
- 在接受PCI的患者中,建议定期对高尿路血症进行查.
- 密切监测和积极的尿酸降低疗法可能是必要的,对于PCI后的高尿血患者.
更多相关视频
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.4K
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
24.4K
相关概念视频
01:27Angina II: Classification
38
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
38
01:30Acute Coronary Syndrome I: Introduction
72
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
72
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:27Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
01:28Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
46
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
46